Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981
Source: The American Journal of Drug and Alcohol Abuse - Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research
More News: Addiction | Alcoholism | Clinical Trials | COVID-19 | Fentanyl | International Medicine & Public Health | Pandemics | Statistics | Study | Substance Abuse | Women